Selected article for: "CAL group and IVIG resistance"

Author: Kang, Soo Jung; Kim, Nam Su
Title: Association of Toll-like receptor 2-positive monocytes with coronary artery lesions and treatment nonresponse in Kawasaki disease
  • Document date: 2017_7_31
  • ID: tk1bxztw_25
    Snippet: Eleven patients with KD developed CALs 1 month after the ini tial diagnosis and 10 patients were IVIG nonresponders. Pa tients with CALs at the time of initial diagnosis, but whose coro nary z scores normalized after 1 month, were considered to have transient lesions and were categorized under the CAL () group, according to the method previously proposed by Yoshi mura et al. 2) in their study correlating Nterminal probrain natri uretic peptide, C.....
    Document: Eleven patients with KD developed CALs 1 month after the ini tial diagnosis and 10 patients were IVIG nonresponders. Pa tients with CALs at the time of initial diagnosis, but whose coro nary z scores normalized after 1 month, were considered to have transient lesions and were categorized under the CAL () group, according to the method previously proposed by Yoshi mura et al. 2) in their study correlating Nterminal probrain natri uretic peptide, CALs, and IVIG resistance in the acute stage of KD. The percentage of IVIG nonresponders did not significantly differ between the CAL (+) and CAL () groups (3 out of 11 pati ents, 27.3%, versus 7 out of 20 patients, 35%, respectively). The percentage of CAL (+) patients was not significantly different between IVIG nonresponders and IVIG responders (3 out of 10, 30%, versus 8 out of 21, 38.1%, res pectively).

    Search related documents:
    Co phrase search for related documents
    • acute stage and initial diagnosis: 1
    • acute stage and ivig resistance: 1, 2
    • acute stage and KD acute stage: 1, 2, 3, 4, 5, 6
    • CAL group and ivig resistance: 1, 2, 3, 4
    • CAL group and KD acute stage: 1
    • initial diagnosis and ivig resistance: 1
    • initial diagnosis and KD acute stage: 1
    • ivig resistance and KD acute stage: 1, 2
    • ivig resistance and KD patient: 1